ELAN
Elanco Animal Health Incorporated
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$24.46
+0.18%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
20.5x
EV/EBITDA
20.2x
Market Cap
$12.22B
MomentumView details →
1D Return
+0.18%
YTD Return
+8.73%
RSI (14)
52.5
ValuationView details →
P/E (Fwd)
20.5x
EV/EBITDA
20.2x
Market Cap
$12.22B
RSI (14)
52.5
MomentumView details →
1D Return
+0.18%
YTD Return
+8.73%
SummaryUpdated Jun 1, 2026
Elanco Animal Health Incorporated (NYSE:ELAN) is a leading global animal health company that develops, manufactures, and markets products for both companion animals (pets) and farm animals. Founded in 1954 as a division of Eli Lilly and Company, Elanco operated as part of the pharmaceutical giant for over six decades before being spun off as an independent public company in September 2018. The company is headquartered in Greenfield, Indiana, and has established itself as one of the largest animal health companies worldwide, serving veterinarians, pet owners, and livestock producers across more than 90 countries.
Similar companies
Latest newsMore news →
Elanco Animal Health completed a 25,000-square-foot expansion of its manufacturing facility in Elwood, Kansas, to boost monoclonal antibody production.9d agoKeystone Cooperative, an Indiana-based agricultural cooperative, joined Alloy Partners' One Health Studio as an advisory partner and invested an undisclosed amount, aiming to develop agrifood offerings at the intersection of animal, plant, and human health.11d ago